U.S. Markets closed

China Biologic Products, Inc. (CBPO)


NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
112.62+0.78 (+0.70%)
At close: 4:00PM EDT
People also watch
BSTCCPHICXDCHOLISKBI
Full screen
Previous Close111.84
Open113.03
Bid100.00 x 100
Ask113.90 x 100
Day's Range110.30 - 113.50
52 Week Range96.99 - 137.39
Volume127,934
Avg. Volume173,692
Market Cap3.06B
Beta1.60
PE Ratio (TTM)29.17
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube4 days ago

    ETFs with exposure to China Biologic Products, Inc. : June 22, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to China Biologic Products, Inc. Here are 5 ETFs with the largest exposure to CBPO-US. Comparing the performance and risk of China Biologic Products, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)

  • China Biologic Products, Inc. :CBPO-US: Earnings Analysis: Q1, 2017 By the Numbers : June 16, 2017
    Capital Cube10 days ago

    China Biologic Products, Inc. :CBPO-US: Earnings Analysis: Q1, 2017 By the Numbers : June 16, 2017

    Categories: Yahoo FinanceGet free summary analysis China Biologic Products, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of China Biologic Products, Inc. – Baxter International Inc., GlaxoSmithKline plc Sponsored ADR, Hemispherx Biopharma, Inc., Gilead Sciences, Inc., Novavax, Inc. and China Pharma Holdings, Inc. (BAX-US, GSK-US, ... Read more (Read more...)

  • Capital Cube17 days ago

    China Biologic Products, Inc. – Value Analysis (NASDAQ:CBPO) : June 9, 2017

    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives China Biologic Products, Inc. a score of 91. Our analysis is based on comparing China Biologic Products, Inc. with the following peers – Baxter International Inc., GlaxoSmithKline plc Sponsored ADR, Hemispherx Biopharma, Inc., Gilead Sciences, Inc., Novavax, Inc., China Pharma Holdings, Inc. and Sinovac Biotech Ltd. (BAX-US, ... Read more (Read more...)